FDA meeting on September 20-21, 2016

Posted in Latest News on September 23, 2016.

pharmacy-pic2

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.



More Latest News

2021-2022 Annual Report and Long-Range Plan Released 
October 31, 2022

The Annual Report and Long-Range Plan for Fiscal Year 2021-22 has been published. Click here for more information. Continue reading


Hometown Heroes
October 12, 2022

The Florida Department of Health, Division of Medical Quality Assurance is proud to highlight the Florida Hometown Heroes Housing Program. Continue reading